Current allergy and asthma reportsHumansAnaphylaxisBiological ProductsOmalizumabFood Hypersensitivity
Using Biologics in the Prevention of Anaphylaxis.
Daniel Song, Amika K Sood, Stephen A Schworer, Onyinye I Iweala, Mildred Kwan
Published: 202510.1007/s11882-025-01224-7
Abstract
PURPOSE OF REVIEW: Until recently, the management of anaphylaxis has been dependent on the avoidance of known triggers combined with the emergent treatment of immediate and, possibly, fatal hypersensitivity reactions. The approval of omalizumab for t…
Preview only. Read the full abstract at the source